This study assesses whether patients with pancreatic cancer who undergo surgery experience improved outcomes following the implementation of a multidisciplinary care pathway, specifically an enhanced recovery after surgery (ERAS) program. This pathway includes various interventions in the preoperative, intraoperative, and postoperative care of these patients, all aimed at enhancing their health status and postoperative results.
This prospective observational study is conducted by the same surgical team at two high-volume pancreatic cancer referral centers in Greece. Patients undergoing elective pancreatic surgery are prospectively enrolled and managed according to a standardized ERAS protocol (ERAS group). A control group, which received standard perioperative care before the implementation of ERAS, was retrospectively selected and matched based on demographic and clinical parameters. The primary study endpoint is the length of hospital stay (LOS), while secondary endpoints include 30-day mortality and morbidity.
Study Type
OBSERVATIONAL
Enrollment
170
ERAS group follows the enhanced recovery after surgery program which involves 20 elements
University of Thessaly
Larissa, Greece
RECRUITINGimpact on length of stay
total number of days spent in the hospital including any readmission
Time frame: within 30 days of surgery
impact on overall morbidity
number of any perioperative adverse events
Time frame: within 30 days from surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.